- Approval Id
- 9e1da656fff878aa
- Drug Name
- ACTAPIN TABLET 5MG
- Product Name
- ACTAPIN TABLET 5MG
- Approval Number
- SIN13537P
- Approval Date
- 2008-08-25
- Registrant
- TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
- Licence Holder
- TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- TABLET
- Dosage
- <p><strong>Posology</strong><br>
Posology and method of administration<br>
The usual starting dose is 5 mg daily. May if necessary be increased to 10 mg daily. It is not necessary to adjust the dose of amlodipine during co-administration of thiazides, beta-blockers or ACE inhibitors (angiotensin-converting enzymes). Normal dosage regimens are recommended. Amlodipine, used at similar doses in elderly and younger patients, is equally well tolerated. The efficacy and safety in children has not been investigated.</p>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>Indications</strong></p>
<ul class="dash">
<li>Hypertension</li>
<li>Chronic Stable angina and/or Prizmetal/variant angina.</li>
</ul>
- Contraindications
- <p><strong>Contraindications</strong><br>
Hypersensitivity to dihydropyridines (amlodipine, nifedipine, felodipine, isradipine). Or any of the excipients.<br>
Pregnancy (see Pregnancy and Lactation – <em>please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information</em>)<br>
Severe hypertension.</p>
- Atc Code
- C08CA01
- Atc Item Name
- amlodipine
- Pharma Manufacturer Name
- TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
